Jaji, Alma A.
HRN: 05-59-84 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/01/2022
AZITHROMYCIN 500MG TABLET (TAB)
06/01/2022
06/05/2022
ORAL
500mg
OD
S/P NSVD Pre Eclampsia With Severe Features,
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes